Navigation Links
Flu Widespread in 47 States, Vaccine 'Moderately' Effective: CDC
Date:1/14/2013

By Steven Reinberg
HealthDay Reporter

FRIDAY, Jan. 11 (HealthDay News) -- Flu continues its march across the United States, with 47 states now reporting widespread influenza activity, up from 41 last week, federal health officials reported Friday.

However, flu has begun to subside in some areas, especially in the Southeast, where it showed up first.

The U.S. Centers for Disease Control and Prevention also reported that the current vaccine was found to be about 60 percent effective in warding off illness, which means it offers "moderate" protection from the flu, which is particularly severe this season.

Flu activity is worsening as peak flu season -- usually late January -- nears, CDC officials said at a news conference.

"Most of the country has seen, or is seeing, a lot of flu, and this may continue for a number of weeks," said CDC director Dr. Thomas Frieden.

"We are continuing to see influenza activity elevated in most of the U.S.," he added. "It may be decreasing in some areas, while other areas in the country, particularly the West, appear to be on the upswing."

Two more children died from flu complications last week, bringing the total to 20 youngsters this season, Frieden said.

The CDC does not keep an up-to-date tally of adult deaths.

Although flu remains at epidemic levels, the rate of doctor's visits for flu have dropped, Frieden said. "That's the trend," he said, adding that "the next week or two will show whether we have, in fact, crossed the peak or whether we'll see a resumption of increase."

Twenty-four states and New York City are reporting a high level of flu, down from 29 states last week. Sixteen states are reporting moderate levels, up from nine a week ago, Frieden said.

It's still not too late to get a flu shot, the CDC said. Researchers who evaluated the flu vaccine in a study of more than 1,000 children and adults found it 62 percent effective in warding off flu, according to a report in the Jan. 11 edition of the CDC's Morbidity and Mortality Weekly Report.

"The take-home message is that the flu vaccine is moderately effective this year, and people who are vaccinated have about a 60 percent lower risk of getting the flu compared to someone who is not vaccinated," Dr. Edward Belongia, an epidemiologist and a lead researcher on the report, said in a statement Friday. "It's a safe vaccine that can help prevent the flu and its complications in both children and adults," he said.

The CDC recommends that everyone 6 months and older get vaccinated. The agency urges people at higher risk for severe disease -- including young children, pregnant women, anyone with a chronic health problem and the elderly -- to get the vaccine.

However, spot shortages of vaccine and the antiviral drug Tamiflu may make preventing and treating the flu more difficult for some people.

The pharmaceutical company Roche is reporting shortages of the liquid form of Tamiflu, according to USA Today. Liquid Tamiflu is often given to children unable to swallow pills.

U.S. Food and Drug Administration spokeswoman Sarah Clark-Lynn told The New York Times that the FDA is working with the company that markets Tamiflu, Genentech, to increase supplies. The agency is also telling pharmacists that in emergencies they can compound the adult Tamiflu capsules to make liquid versions for children.

Meanwhile, drug maker Sanofi is reporting a shortage of Fluzone vaccine, according to published reports.

Sanofi has said it has produced all the vaccine it can for this year and has started work on next year's vaccine.

"The FDA is aware of reports of some spot shortages of influenza vaccine," FDA spokeswoman Rita Chappelle said. "At this time, we believe that there is an adequate supply available, but there may be some delays in distribution. We think it is important that pharmacies, hospitals, and doctors work closely with their distributors, as they are in the best position to advise on these issues."

Dr. John Treanor, a professor of infectious disease at University of Rochester in New York, said Fluzone is by far the most widely used flu vaccine in the United States.

"But at this point obviously most people who are going to be vaccinated already have been, so the effects of a vaccine shortage would probably be minimal -- although frustrating for those people who do still want vaccine," he said.

Shortages of Tamiflu would be more problematic because this is the middle of the outbreak, Treanor said.

"General recommendations are that antiviral therapy should be targeted to those individuals with higher risk of influenza complications or with severe disease, and not used routinely in otherwise healthy individuals with uncomplicated flu," he said.

Dr. Marc Siegel, an associate professor of medicine at NYU Langone Medical Center in New York City, said 135 million doses of flu vaccine were manufactured and 128 million doses have been distributed. "The question is how many of the flu shots that were distributed actually got used," he said.

Siegel said Tamiflu is the most effective antiviral for flu, although there are alternatives. "Tamiflu significantly reduces symptoms, severity and length of contagion," he said.

Siegel is concerned, however, that people might panic and hoard Tamiflu. "We need calm... The flu should be declining by a month from now," he said.

More information

For more information on flu, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: John J. Treanor, M.D., professor of infectious disease, University of Rochester, N.Y.; Marc Siegel, M.D., associate professor of medicine, NYU Langone Medical Center, New York City; Rita Chappelle, spokeswoman, U.S. Food and Drug Administration; Jan. 11, 2013, press conference with: Thomas Frieden, M.D., M.P.H., director, Joseph Bresee, M.D., chief of the Epidemiology and Prevention Branch, Influenza Division, both U.S. Centers for Disease Control and Prevention; Jan. 11, 2013, Morbidity and Mortality Weekly Report; Jan. 10, 2013, The New York Times


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Benefits of Widespread Statin Use Outweigh Risks: Study
2. Widespread exposure to BPA substitute is occurring from cash register receipts, other paper
3. Supplement Use Widespread Among Americans
4. Young scientist helps identify cause of widespread eye disease
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Young girls more likely to report side effects after HPV vaccine
7. Preteens More Likely to Report HPV Vaccine Side Effects
8. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
9. Early Study Finds Some Promise for Lung Cancer Vaccine
10. From a Failed Vaccine, New Insights Into Fighting HIV
11. From herd immunity and complacency to group panic: How vaccine scares unfold
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... , ... US Sport Camps is pleased to announce the addition of junior ... as the host site and directing the camps is PGA Professional and 2008 Iowa ... in recent years around Des Moines and are fortunate to have such a well-respected ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... A lot ... past 35 years. A president has access to health and wellness resources most Americans ... free world, no single individual has a schedule as frenetic as the U.S. President. ...
(Date:2/12/2016)... ... February 12, 2016 , ... Healthcare careers in the medical laboratory, nursing, ... via the website of healthcare staffing leader Aureus Medical Group during the month of ... travel therapy positions and in travel and direct hire opportunities in other ...
(Date:2/12/2016)... ... , ... The Central Coast Autism Spectrum Center (CCASC) invites teens ages 11-18 to its annual ... for teens with and without special needs to gather in a safe and supportive environment. ... dance will take place on Saturday, Feb. 13 from 7 to 9:30 p.m. at Elks ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... in the field of long term care. With that, says Patrick Loughney, president ... professionals in administrative roles in long term care environments. His company, which offers ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... Market research report titled Chronic Inflammation Global Clinical ... a snapshot of the global clinical trials landscape ... clinical trials by Region, Country (G7 & E7), ... point status and reviews top companies involved and ...
(Date:2/11/2016)... -- - Cardiac Marker Diagnostic Testing ... Cancer Therapy. - European Point of Care Diagnostic ... - Key Diagnostic Testing Markets. - Molecular Diagnostics ... Testing. - Molecular Diagnostics in Infectious Disease Testing. ... Products World Markets. - Point of Care Diagnostic ...
Breaking Medicine Technology: